Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies. A newly released EY report indicates that US merger and acquisition activity in March 2026 maintained a steady pace, driven by strategic deals in technology and healthcare sectors. The report provides a month-end snapshot of dealmaking trends, with a focus on valuation dynamics and regulatory considerations.
Live News
EY has published its latest insights on US M&A activity, covering the month of March 2026. The report, released in recent weeks, offers a detailed look at deal flow, sector trends, and the broader macroeconomic factors influencing transaction activity during the period. According to the report, overall deal volume remained consistent with the levels observed in the early months of the year, though the mix of deal types shifted notably.
Strategic buyers continued to drive the majority of transactions, with corporate acquirers pursuing bolt-on acquisitions to strengthen core businesses. The technology and healthcare sectors attracted significant interest, reflecting ongoing digital transformation efforts and consolidation in life sciences. Cross-border M&A activity also featured prominently, with both US firms targeting overseas assets and foreign investors seeking US-based opportunities.
The report notes that valuation expectations remained a key point of negotiation, with buyers and sellers often needing additional time to align on price. Regulatory scrutiny, particularly around antitrust considerations, was cited as a factor in several large proposed deals, contributing to longer closing timelines. Financing conditions, including access to debt markets and interest rate expectations, were described as supportive but with some tightening compared to earlier in the year.
EY’s analysis is based on publicly announced transactions with a disclosed value of $50 million or more, as well as a survey of dealmakers and industry participants. The full report includes sector-level breakdowns and regional analysis.
EY Report Highlights Steady US M&A Activity in March 2026Analytical platforms increasingly offer customization options. Investors can filter data, set alerts, and create dashboards that align with their strategy and risk appetite.Observing market sentiment can provide valuable clues beyond the raw numbers. Social media, news headlines, and forum discussions often reflect what the majority of investors are thinking. By analyzing these qualitative inputs alongside quantitative data, traders can better anticipate sudden moves or shifts in momentum.EY Report Highlights Steady US M&A Activity in March 2026Combining different types of data reduces blind spots. Observing multiple indicators improves confidence in market assessments.
Key Highlights
- Deal Volume Steady: The number of transactions in March 2026 was broadly in line with the average monthly volume seen in the first quarter, suggesting sustained appetite for M&A among corporate and financial sponsors.
- Sector Focus: Technology and healthcare remained the most active sectors, with deals concentrated in software, digital health, and medical devices. Energy and industrials also saw notable activity, driven by renewable energy transitions and reshoring efforts.
- Valuation Dynamics: The report indicates that valuation gaps persisted in certain sectors, with sellers expecting higher premiums while buyers remained disciplined on pricing. Average deal multiples were described as stable compared to recent months.
- Regulatory Environment: Increased antitrust scrutiny was noted, particularly for large horizontal deals. This has led to more pre-close planning and, in some cases, the use of divestiture remedies to secure regulatory approval.
- Financing Conditions: Debt availability remained generally favorable, though rising interest rates in early 2026 led to slightly higher borrowing costs for leveraged transactions. Cash-rich corporate balance sheets continued to fund all-cash deals.
EY Report Highlights Steady US M&A Activity in March 2026Many investors underestimate the importance of monitoring multiple timeframes simultaneously. Short-term price movements can often conflict with longer-term trends, and understanding the interplay between them is critical for making informed decisions. Combining real-time updates with historical analysis allows traders to identify potential turning points before they become obvious to the broader market.Some traders adopt a mix of automated alerts and manual observation. This approach balances efficiency with personal insight.EY Report Highlights Steady US M&A Activity in March 2026Predictive analytics are increasingly used to estimate potential returns and risks. Investors use these forecasts to inform entry and exit strategies.
Expert Insights
The EY report provides a useful window into the current state of the US M&A market, suggesting that strategic motivations rather than financial engineering continue to underpin most transactions. Industry observers may view the steady activity as a sign of corporate confidence, though the extended negotiation periods and regulatory hurdles could moderate the pace in coming months.
From an investment perspective, the emphasis on technology and healthcare M&A points to areas where consolidation is likely to persist as companies seek scale and capabilities. However, the report’s findings also highlight the importance of careful due diligence, particularly around valuation and regulatory risk. Dealmakers may need to account for potential changes in antitrust policy and interest rate trajectories.
While the data in the EY report is backward-looking, it offers insights that could inform strategic planning for companies considering acquisitions or divestitures in the near term. The cautious tone around valuations and regulatory timelines suggests that while M&A remains an active avenue for growth, the path to closing may be more complex than in previous cycles. As always, individual transaction outcomes will depend on sector-specific factors and the ability of parties to align on terms.
EY Report Highlights Steady US M&A Activity in March 2026Diversifying data sources reduces reliance on any single signal. This approach helps mitigate the risk of misinterpretation or error.The integration of multiple datasets enables investors to see patterns that might not be visible in isolation. Cross-referencing information improves analytical depth.EY Report Highlights Steady US M&A Activity in March 2026Many investors underestimate the importance of monitoring multiple timeframes simultaneously. Short-term price movements can often conflict with longer-term trends, and understanding the interplay between them is critical for making informed decisions. Combining real-time updates with historical analysis allows traders to identify potential turning points before they become obvious to the broader market.